News and Announcements

Issue of Equity and Total Voting Rights

In accordance with AIM Rule 17, shareholders are advised that Gemfields have issued and allotted 30,000 new ordinary shares of USD0.00001 each in the Company (“Ordinary Shares”) following the exercise of employee share options.

Disclosure of beneficial interests in securities

In compliance with paragraph 3.83(b) of the JSE Listings Requirements, shareholders are advised that Gemfields received formal notification on 29 September 2021 from Assore International Holdings Limited (“AIHL”) that AIHL acquired, on 29 September 2021, a beneficial interest in 156,863,106 ordinary shares of the Company. Following the acquisition, AIHL held a total of 305,810,560 ordinary shares in the Company representing 26.17% of the total issued share capital in the Company.

Disclosure of beneficial interests in securities

In compliance with paragraph 3.83(b) of the JSE Listings Requirements, shareholders are advised that Gemfields received formal notification on 28 September 2021 of disposals on 27 September 2021 by various entities associated with Dr Christo Wiese and his family and associates of a beneficial interest in 154,658,406 ordinary shares of the Company.

Invitation to Shareholders: the Company’s Remuneration Policy

At the Company’s AGM on 24 June 2021, more than 25% (25.19%) of the votes were cast against non-binding advisory vote number 1, to endorse the Company’s Remuneration Policy. The non-binding advisory vote number 2, to endorse the Company’s Remuneration Implementation Report, was carried.

Non-Executive Director Resignation

Gemfields advises that Dr Christo Wiese resigned as a Non-Executive Director of the Company on, and with effect from, 23 September 2021. The Company is in the process of confirming a replacement for Dr Wiese.